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A B S T R A C T
A 34-year-old man presented with heart failure (HF). He suffered opportunistic infections and was shown
to be human immunodeﬁciency virus (HIV)-positive (viral load: 156,013 copies/mL) and have low CD4
lymphocytes (3/mm3), so he was initially treated for the opportunistic infections. Initial investigations
showed high elevation of brain natriuretic peptide (BNP: 969 pg/mL). Transthoracic echocardiography
showed an enlarged left ventricle (LV: 70 mm), a reduced LV ejection fraction (EF: 19%), but no LV
hypertrophy or signiﬁcant valvular diseases. After treatments for the infections, we started standard HF
medications. Cardiac catheterization, after recovery from the opportunistic infections with negative
inﬂammatory markers, showed no signiﬁcant coronary stenosis, and endomyocardial biopsy did not show
ﬁndings of myocarditis, without HIV structural protein on immunohistochemistry. Despite reduced EF, the
cardiac output was elevated at 7.1 l/min [cardiac index (CI): 4.3 l/min/m2] and the systemic vascular
resistance index was decreased at 1358 dynes s/cm5 m2. Hematologists began anti-retroviral therapy; the
viral load was gradually reduced to negative, and the CD4 count was increased to 50/mm3 at Day 182. EF
was accordingly improved up to 54%, but the cardiac output decreased to a normal level at 3.9 l/min (CI:
2.4 l/min/m2), leading to normalization of plasma BNP (<5 pg/mL). This case indicates that high cardiac
output might be involved in the pathogenic mechanisms of HIV-related HF.
<Learning objective: The etiology of HIV-related HF remains unclariﬁed. We report on a man with HIV-
associated HF. There were no apparent causes of the HF, but the patient did demonstrate high cardiac
output despite impaired systolic function. After anti-retroviral therapy, his systolic function was
improved with a reduction and normalization of cardiac output. Therefore, this case indicates that high
cardiac output might be involved in the pathogenic mechanisms of HIV-related HF.>
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Heart failure associated with human immunodeﬁciency virus
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cardiotoxicity, and inﬂammatory cytokinemia have been suggested
aspossible causes; however, the preciseetiology ofHIV-relatedheart
failure remains unclariﬁed. We report on an HIV-infected man with
heart failure. He did not have any of the causative factors described
above, but did demonstrate high cardiac output despite impaired
systolic left ventricular (LV) function. After anti-retroviral therapy,
his LV function improved, with a reduction and normalization of
cardiac output. This case indicates that high cardiac output might be
involved in the pathogenic mechanisms of HIV-related heart failure. reserved.
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In October 2011, a 34-year-old man presented at the
Hematology Department with HIV infection accompanied by
congestive heart failure. In September 2011, he had begun to
experience exertional fatigue and was admitted to another
hospital because of a fever of unknown origin. He presented with
infections of Pneumocystis jirovecii and cytomegalovirus with HIV-
positivity (viral load: 156,013 copies/mL) and low CD4 lympho-
cytes (3/mm3). Blood culture at the previous hospital had not
demonstrated sepsis. He was initially treated with trimethoprim-
sulfamethoxazole and ganciclovir, and had been recovering from
the pulmonary infections. After successful treatment of the
opportunistic infections (pneumonia) for one week, he was
transferred to our hospital. His past medical history did not reveal
any cardiovascular diseases and he had not taken medications for
them.
After admission to our hospital, he was referred to the
Cardiovascular Medicine Department because he had heart failure,Fig. 1.
(A) Chest radiograph of this patient on admission, showing enlarged heart an
sinus tachycardia, mild left axis deviation, negative T-wave in V4–6 leads, a
showing enlarged left ventricle and reduced left ventricular ejection fraction 
was compatible with dilated cardiomyopathy. CTR, cardiothoracic ratio; LVDeven after one month of recovery from the opportunistic infections
(pneumonia). On physical examination, his blood pressure was
104/82 mmHg and his pulse rate was 107 beats/min, with New
York Heart Association Classiﬁcation-II. He had S3 and S4 gallops
without signiﬁcant murmur. There were no rales on the lung and
no edema of the extremities. Initial investigations showed high
elevation of brain natriuretic peptide (BNP) at 969.2 pg/mL. Renal,
liver, and thyroid function test results were all normal, without
signiﬁcant anemia, cytokinemia, or nutrient deﬁciency including of
selenium. A chest radiograph showed heart enlargement and slight
pulmonary congestion (Fig. 1A). An electrocardiogram indicated a
negative T-wave in V4–6 leads and a QS pattern in V1–2 leads
(Fig. 1B). Transthoracic echocardiography showed an enlarged LV
(LV end-diastolic diameter of 70 mm, LV end-systolic diameter of
64 mm) and a reduced LV ejection fraction (EF) of 19%, without LV
hypertrophy or signiﬁcant valvular diseases (Fig. 1C); these
ﬁndings were compatible with dilated cardiomyopathy. Magnetic
resonance imaging demonstrated no late gadolinium enhance-
ment. After treatments of the opportunistic infections, C-reactived bilateral inﬁltrates. (B) Twelve-lead electrocardiogram recorded on admission;
nd QS pattern in V1–2 leads were observed. (C) Transthoracic echocardiography,
(19%), without left ventricular hypertrophy or signiﬁcant valvular diseases, which
d, left ventricular end-diastolic diameter; LVEF, left ventricular ejection fraction.
Fig. 2.
(A) Endomyocardial biopsy showed cardiomyocyte hypertrophy, but no
signiﬁcant cell death or myocarditis. (B) Parameters of this patient before
and after (day 182) cART treatment. cART, combination antiretroviral
therapy; BT, body temperature; HR, heart rate; BP, blood pressure; WBC,
white blood cells; Hb, hemoglobin; CRP, C-reactive protein; LVEF, left
ventricular ejection fraction; CI, cardiac index; SVRI, systemic vascular
resistance index; BNP, brain natriuretic peptide.
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heart failure medications consisting of a beta-blocker, angiotensin-
converting enzyme inhibitor, an anti-aldosterone agent, and
diuretics.
On Day 33, with the patient in a stable condition after recovery
from the opportunistic infections with negative CRP, we performed
cardiac catheterization. Coronary angiography showed no signiﬁ-
cant stenosis. Endomyocardial biopsy showed cardiomyocyte
hypertrophy but no signiﬁcant cell death or myocarditis (Fig. 2A).
Cytomegalovirus and p24 protein, which is an HIV structural
protein, were negative on immunohistochemistry. The LV was still
dilated with reduced EF of 39%, but the cardiac output was
paradoxically elevated at 7.1 l/min [cardiac index (CI): 4.3 l/min/m2]
and the systemic vascular resistance index (SVRI) was decreased at
1358 dynes s/cm5 m2 (LV end-diastolic diameter: 64.7 mm, LV end-
systolic diameter: 55.5 mm, LV end-diastolic volume: 229.7 mL, LV
end-systolic volume: 139.6 mL, stroke volume: 90 mL, heart rate:
78/min, body surface area: 1.66 m2). After cardiac catheterization,
hematologists began highly active combination antiretroviral
therapy (cART) with raltegravir, darunavir, and ritonavir. After
cART, the viral load was gradually reduced to negative and the CD4
count was increased to 50/mm3 at Day 182. LVEF was accordingly
improved up to 54%, but the cardiac output was decreased to a
normal level of 3.9 l/min (CI: 2.4 l/min/m2), leading to normalization
of plasma BNP (<5 pg/mL) (Fig. 2B). With no side effects of the cART,
the patient was discharged and followed up at both hematologic and
cardiovascular outpatient clinics.Discussion
Myocardial diseases associated with HIV were recognized early
in the epidemic [1]. As the HIV-infected population ages, heart
failure prevalence and mortality including cardiac sudden death are
increasing [2]. It was suggested that echocardiographic abnormali-
ties were frequently observed in HIV-positive patients [3]. HIV-
associated myocarditis, selenium deﬁciency, cardiotoxicity from
drugs [4], inﬂammatory cytokinemia, and nutritional deﬁciencies
have been suggested as possible causes of HIV-related heart failure
[5]; however, the precise mechanisms and pathogenesis remain
unresolved.
Our patient presented with heart failure-like dilated cardiomy-
opathy with HIV-positivity at the stage of acquired immunodeﬁcien-
cy syndrome (AIDS). He did not have any of the above causative
conditions, but showed HIV viremia with signiﬁcantly elevated virus
copy number. Myocardial dysfunction is often a complication in
patients with sepsis [6] and we could not rule out the possible
involvement of sepsis-associated myocardial dysfunction in the
present case. However, our case had opportunistic infections:
pneumonia at a previous hospital one week before admission to
our hospital, but he did not have sepsis. After successful treatment of
the infections, his condition became stable upon admission to our
hospital. On the 42nd day from the initial pulmonary infection,
clinical examinations at the time of cardiac catheterization before the
initiation of cART did not show any ﬁndings of inﬂammation, namely,
fever, or the elevation of CRP and white blood cell count. His heart
failure was still maintained after optimal heart failure medications
and successful recovery from the opportunistic infections before
cART. Cardiac catheterization on that occasion demonstrated the
presence of high cardiac output and low SVRI, with reduced LVEF. To
the best of our knowledge, this is the ﬁrst report demonstrating that
HIV viremia might be one of the causes of high-cardiac-output heart
failure. The patient did not have any established causes of high
cardiac output: hyperthyroidism, fever, systemic inﬂammation,
dehydration, thiamine deﬁciency, or anemia [7]. After cART, LVEF
andLV were improved, interestingly accompanied bya reductionand
normalization of cardiac output. Inﬂammatory markers (white blood
cell count, serum amyloid-A protein, and CRP) were at normal levels,
butHIV levelswere signiﬁcantly elevatedbefore cART, soit ispossible
that the decreased systemic vascular resistance and high cardiac
output could have been caused by the high HIV levels, without any
clinical evidence of systemic inﬂammation.
It has been reported that cytokines promote the expression of
inducible nitric oxide synthase (iNOS) in cardiomyocytes, inducing
myocarditis [8]. However, in this case, endomyocardial biopsy
showed no signiﬁcant cell death or myocarditis. The value of
interleukin-6 that we measured was within the normal range
(3.9 pg/mL), and we did not measure other cytokines such as tumor
necrosis factor-alpha (TNF-alpha) and did not examine iNOS
induction in this case. Gonza´lez-Nicola´s et al. [9] reported that
increased circulating TNF-alpha and nitric oxide (NO) were
detected in HIV-infected patients and higher TNF-alpha and NO
plasma levels were associated with higher HIV viral load.
Therefore, in untreated HIV-infected patients, higher viral load
might cause high plasma levels of NO and promote dysregulated
vascular tone and uncontrolled vasodilation, decreased systemic
vascular resistance, and high cardiac output, resulting in progres-
sive deterioration of cardiac function and heart failure.
It might seem a little strange that this patient had impaired
systolic function despite no ﬁnding of histological myocardial
injury in endomyocardial biopsy. It is possible that the increases in
vascular permeability and ﬂuid accumulation might have caused
massive elevation of preload, and the enhanced expression of iNOS
might have resulted in dilation of the heart.
The accumulation of more cases might conﬁrm our ﬁndings.
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This case indicates that high cardiac output induced by high-
level HIV viremia might in part be involved in the pathogenic
mechanism of HIV-related heart failure. Comprehensive and
prompt treatments against high HIV load and optimal cardiovas-
cular assessment by cardiologists could lead to the successful
improvement of cardiac function associated with the remission of
high-level HIV viremia.
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